ArticleJournal of cardiothoracic surgery2026
A structured pre-procedural risk mitigation strategy for ultra-high-risk TAVR in a nonagenarian with extreme aortic valve calcification: a case report using a balloon-expandable valve and proactive ECMO backup.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTranscatheter aortic valve replacement (TAVR) in nonagenarians with extensive aortic valve calcification is associated with a substantial risk of intraprocedural circulatory collapse. CASE PRESENTATION: This case report describes a structured pre-procedural risk mitigation strategy integrating a balloon-expandable valve system and a pre-emptive, "wet-prepared" extracorporeal membrane oxygenation (ECMO) backup. A 97-year-old man with severe symptomatic aortic stenosis (peak velocity = 4.76 m/s; aortic valve calcium volume = 1178 mm³) underwent transfemoral TAVR using a structured approach incorporating precision imaging, careful device selection using a domestic Chinese balloon-expandable valve system (Prizvalve
conclusionsThis case demonstrates the feasibility of a structured, pre-procedural risk mitigation strategy for TAVR in an exceptionally high-risk patient. The approach enabled the management of intraprocedural circulatory collapse. In this setting, the balloon-expandable valve platform demonstrated procedural characteristics that were well suited for this complex anatomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.